Weather Tonight: 10°c Heavy rain Morning: 11°c Light rain

News

HEADLINES:
RSS

GlaxoSmithKline plc

Related topics: 

Latest articles

Glaxo £300m deal on nicotine vaccine

16.11.09
Smokers could receive a vaccine to help kick the nicotine habit if GlaxoSmithKline’s latest $500 million (£300 million) deal works out ... more

Metals add lustre to miners as dollar is in the doldrums

09.11.09
The price of gold traded at a record high of $1108.00 an ounce on world markets today in response to a weaker dollar ... more

Glaxo cashes in on swine flu jab rush

28.10.09
GlaxoSmithKline, the drug company producing the bulk of Britain’s swine flu vaccine, said third-quarter pre-tax profit soared 23% to £1.91 billion as the firm cashed in from a boost in emerging markets and H1N1 drugs ... more

Glaxo lifted after US approves drug

27.10.09
GlaxoSmithKline today received a boost after the Food and Drug Administration in the US approved its leukaemia medicine Arzerra ... more

Glaxo’s £11m for new science park

13.10.09
GlaxoSmithKline announced it is spending £11 million creating a science park in Stevenage that will house 1500 biotech experts ... more

Glaxo starts to shift swine flu vaccine worth £2.2bn

06.10.09
GlaxoSmithKline announced it had started to dispatch its swine flu vaccine around the world and said it has received contracts for 440 million doses of its pandemic vaccine ... more

Swine flu’s £1.8bn boost for Glaxo

05.08.09
GlaxoSmithKline is set to cash in on £1.8 billion from the rush for its swine flu vaccine, after nine more governments gave the pharma giant orders for another 96 million doses ... more

Glaxo charges £6 for £1 swine flu vaccine

22.07.09
Drug company producing most of Britain’s swine flu vaccine accused of profiteering from the pandemic as it hikes prices with 600% mark-up... more

Q&A: Swine flu vaccine

22.07.09
Who is making the vaccine?... more

GlaxoSmithKline’s double boost on cancer treatments

09.07.09
Pharma giant GlaxoSmithKline had a double injection of health, when the World Health Organisation approved its cervical cancer vaccine Cervarix and the British medical watchdog said it would reconsider its block on breast cancer treatment Tyverb’s use in the National Health Service... more

Glaxo gets a boost from cervical cancer drug

07.07.09
British drug giant GlaxoSmithKline received a boost today after research into its cervical cancer vaccine Cervarix showed it is the only treatment to protect against five of the most common viruses associated with the disease ... more

Glaxo in £21 million China joint venture

09.06.09
Britain's biggest pharmaceuticals giant GlaxoSmithKline today set up a joint venture with Shenzhen Neptunus to develop influenza vaccines for China ... more

Glaxo gets a fillip after WHO backs vaccine

05.06.09
Pharma giant GlaxoSmith Kline was today given a boost when the World Health Organisation endorsed its vaccine against a diarrhoea-causing virus that kills 500,000 children every year ... more

Long, profitable life of vaccines means it's not just the ill clamouring for them

01.06.09
A dirty-brown brick building close to Northern Line station Mill Hill East is an unlikely place to find the saviour of the pharmaceuticals industry... more

US patent problems damage Glaxo health

22.04.09
The UK’s biggest pharmaceuticals firm, GlaxoSmithKline, blamed competition from American generic drugs as its first-quarter pre-tax profit fell 1.5% to £1.93 billion... more

Glaxo pays £2.5bn for skin specialist

20.04.09
The UK’s biggest pharmaceuticals firm GlaxoSmithKline has bought American skincare specialist Stiefel Laboratories for £2.5 billion... more

Glaxo to co-promote Shire's Vyvanse drug

31.03.09
Shire has struck a deal with GlaxoSmithKline, the world's second largest drugs group, to co-promote its hyperactivity medicine Vyvanse in the United States, sending its shares sharply higher... more

Glaxo revamps pay deal for new CEO Witty

04.03.09
GlaxoSmithKline has revamped the pay deal for its new chief executive Andrew Witty, who took over last May, following past controversies over remuneration at Europe's biggest drugmaker... more

Flu drug orders go to Glaxo and Roche

29.01.09
Health: The Government has ordered drugs by GlaxoSmithKline and Roche as it doubled its stockpile of anti-flu pandemic medicines... more

Glaxo seals drugs deal and Pfizer eyes merger

23.01.09
Health: There was a frenzy of activity in the pharmaceuticals sector with GlaxoSmithKline and Viagra maker Pfizer both involved in multi-million pound deals... more

Anti-obesity pill is going on sale

21.01.09
A pill that causes weight loss has been approved for sale in Britain without a prescription for the first time... more

Glaxo eyes African medical firm Aspen

16.01.09
Health: British pharmaceutical giant GlaxoSmithKline is believed to be eyeing up Africa’s largest pharmaceutical firm, Aspen Pharmacare, for a £940 million takeover... more

Wrongs and rights of a downturn

06.01.09
People tend to think that no one raises money on the stock market in an economic downturn and when share prices are low... more

Bitter pill as drugs giant AstraZeneca chops workers

20.11.08
Pharmaceuticals: Drugs giant AstraZeneca is axeing 250 UK jobs as part of a plan to shed 1400 worldwide... more

Glaxo S Africa deal opens way to emerging markets

23.07.08
GlaxoSmithKline have taken a bold step into the branded generics market place through an alliance with South Africa's Aspen Pharmacare... more

Anger over FDA 'brake on Glaxo'

17.06.08
US watchdog accused of posing new questions to Glaxo as it re-submits previously approved drugs... more

Anger over FDA 'brake on Glaxo'

17.06.08
US watchdog accused of posing new questions to Glaxo as it re-submits previously approved drugs... more

Sticky issue of the RBS rights

20.05.08
Royal Bank of Scotland's share price sagged to 250p yesterday, and suddenly the 200p rights issue price it has set to raise £11 billion of new capital is not so far away... more

Alistair Darling calls in City chiefs to avoid tax row exodus

19.05.08
The Chancellor is to bring senior executives from Britain's leading multinationals "into the tent" in a bid to stave off an exodus abroad of major companies over a tax row... more

Glaxo lung drug gets a US boost

01.05.08
US health regulators say GSK's Advair medicine is safe and effective for the wider treatment of patients with the lung disease COPD... more

More related topics: GlaxoSmithKline plc and

NewsSportShowbiz

Latest pictures



Don't Miss

Steamy scenes for Purnell in Turkish bath

Scheming over the future of the Labour Party continues even in the most unlikely places

All stories

Promotions

Environmental initiatives

Find out how you can help to meet the challenges of climate change in London.


The Open University

Every year The Open University helps thousands of professionals progress in their careers.


Win the Best Seats

In London theatre when you vote for your favourite celebrity spec wearer.


Breast Cancer Care

Donate £1 and leave a message of support for a loved one in the Swarovski Garden of Wishes.


Win an iPodTouch

With Courvoisier when you share your thoughts on this week's cocktail.